PubMed

Hair it is: the long and short of monitoring antiretroviral treatment.

Gandhi M, Greenblatt RM.

Ann Intern Med. 2002 Oct 15;137(8):696-7. No abstract available. PMID: 12379072 [PubMed - indexed for MEDLINE]Related articlesFree article

Summaries for patients. The relationship between levels of the anti-HIV drug indinavir in patients' hair and response to treatment.

[No authors listed]

Ann Intern Med. 2002 Oct 15;137(8):I48. No abstract available. PMID: 12379092 [PubMed - indexed for MEDLINE]Related articles

Relationship between levels of indinavir in hair and virologic response to highly active antiretroviral therapy.

Bernard L, Vuagnat A, Peytavin G, Hallouin MC, Bouhour D, Nguyen TH, Vildé JL, Bricaire F, Raguin G, de Truchis P, Ghez D, Duong M, Perronne C.

Ann Intern Med. 2002 Oct 15;137(8):656-9.PMID: 12379065 [PubMed - indexed for MEDLINE]Related articlesFree article

Indinavir hair concentration in highly active antiretroviral therapy-treated patients: association with viral load and drug resistance.

Servais J, Peytavin G, Arendt V, Staub T, Schneider F, Hemmer R, Burtonboy G, Schmit JC.

AIDS. 2001 May 4;15(7):941-3. No abstract available. PMID: 11399971 [PubMed - indexed for MEDLINE]Related articles

Reduction of HIV-1 viral load in saliva by indinavir-containing antiretroviral regimen.

Liuzzi G, Chirianni A, Clementi M, Zaccarelli M, Antinori A, Piazza M.

AIDS. 2002 Feb 15;16(3):503-4. No abstract available. PMID: 11834971 [PubMed - indexed for MEDLINE]Related articles

Hair versus plasma concentrations as indicator of indinavir exposure in HIV-1-infected patients treated with indinavir/ritonavir combination.

Duval X, Peytavin G, Breton G, Ecobichon JL, Descamps D, Thabut G, Leport C.

AIDS. 2007 Jan 2;21(1):106-8.PMID: 17148976 [PubMed - indexed for MEDLINE]Related articles

Suppression of cerebrospinal fluid HIV burden in antiretroviral naive patients on a potent four-drug antiretroviral regimen.

Polis MA, Suzman DL, Yoder CP, Shen JM, Mican JM, Dewar RL, Metcalf JA, Falloon J, Davey RT Jr, Kovacs JA, Feinberg MB, Masur H, Piscitelli SC.

AIDS. 2003 May 23;17(8):1167-72.PMID: 12819518 [PubMed - indexed for MEDLINE]Related articles

[Highly active initial therapy without resistance development. Even after 6 years still effective HIV therapy]

[No authors listed]

MMW Fortschr Med. 2005 Apr 25;147 Spec No 1:54-5. German. No abstract available. PMID: 16385876 [PubMed - indexed for MEDLINE]Related articles

Differences in durability of treatment with initial PI-based regimens.

Pérez-Elías MJ, Moreno A, Moreno S, Antela A, Dronda F, Muñoz V, Casado JL, Quereda C, Lopez D, Navas E.

HIV Clin Trials. 2003 Nov-Dec;4(6):391-9.PMID: 14628282 [PubMed - indexed for MEDLINE]Related articlesFree article

Compliance with antiretroviral regimens.

Laurence J.

AIDS Read. 2001 Apr;11(4):177, 181. No abstract available. PMID: 11392675 [PubMed - indexed for MEDLINE]Related articles

Continued indinavir versus switching to indinavir/ritonavir in HIV-infected patients with suppressed viral load.

Arnaiz JA, Mallolas J, Podzamczer D, Gerstoft J, Lundgren JD, Cahn P, Fätkenheuer G, D'Arminio-Monforte A, Casiró A, Reiss P, Burger DM, Stek M, Gatell JM; BEST Study Team.

AIDS. 2003 Apr 11;17(6):831-40.PMID: 12660530 [PubMed - indexed for MEDLINE]Related articles

Definition of virologic response and the type of assay used for quantification of viral load may influence the proportion of responders to antiretroviral therapy. APROCO Study Group.

Le Moing V, Chêne G, Masquelier B, Sicard D, Brun-Vézinet F, Reynes J, Raffi F.

J Acquir Immune Defic Syndr. 2000 May 1;24(1):82-3. No abstract available. PMID: 10877502 [PubMed - indexed for MEDLINE]Related articles

Persistent HIV type 1 infection in semen and blood compartments in patients after long-term potent antiretroviral therapy.

Craigo JK, Patterson BK, Paranjpe S, Kulka K, Ding M, Mellors J, Montelaro RC, Gupta P.

AIDS Res Hum Retroviruses. 2004 Nov;20(11):1196-209.PMID: 15588342 [PubMed - indexed for MEDLINE]Related articles

First-line ritonavir/indinavir 100/800 mg twice daily plus nucleoside reverse transcriptase inhibitors in a German multicentre study: 48-week results.

Voigt E, Wickesberg A, Wasmuth JC, Gute P, Locher L, Salzberger B, Wöhrmann A, Adam A, Weitner L, Rockstroh JK.

HIV Med. 2002 Oct;3(4):277-82.PMID: 12444946 [PubMed - indexed for MEDLINE]Related articles

In vivo cell-mediated immunity in subjects with undetectable viral load on protease inhibitor-based versus non-protease inhibitor-based highly active antiretroviral therapy.

Ananworanich J, Nuesch R, Teeratakulpisarn S, Srasuebkul P, Chuenyam T, Siangphoe U, Ungsedhaphand C, Phanuphak P, Ruxrungtham K.

J Acquir Immune Defic Syndr. 2003 Apr 15;32(5):570-2. No abstract available. PMID: 12679711 [PubMed - indexed for MEDLINE]Related articles

The normalized inhibitory quotient of boosted protease inhibitors is predictive of viral load response in treatment-experienced HIV-1-infected individuals.

Winston A, Hales G, Amin J, van Schaick E, Cooper DA, Emery S; CREST investigators.

AIDS. 2005 Sep 2;19(13):1393-9.PMID: 16103770 [PubMed - indexed for MEDLINE]Related articles

Recent advances in the management and treatment of GI and hepatic diseases associated with HIV: Part I.

Boyle BA.

AIDS Read. 2001 Jul;11(7):354-5, 359-61, 363. Review. No abstract available. PMID: 11494705 [PubMed - indexed for MEDLINE]Related articles

Efficacy and safety of indinavir/ritonavir 400/100 mg twice daily plus two nucleoside analogues in treatment-naive HIV-1-infected patients with CD4+ T-cell counts <200 cells/mm3: 96-week outcomes.

Mootsikapun P, Chetchotisakd P, Anunnatsiri S, Boonyaprawit P.

Antivir Ther. 2005;10(8):911-6.PMID: 16430196 [PubMed - indexed for MEDLINE]Related articles

Successful rescue therapy with darunabir (TMC114) in HIV-infected patients who have failed several ritonavir-boosted protease inhibitors.

Poveda E, Blanco F, García-Gascó P, Alcolea A, Briz V, Soriano V.

AIDS. 2006 Jul 13;20(11):1558-60.PMID: 16847414 [PubMed - indexed for MEDLINE]Related articles

Sustained CD4 responses after virological failure of protease inhibitor-containing therapy.

Deeks SG, Grant RM.

Antivir Ther. 1999;4 Suppl 3:7-11. Review.PMID: 16021865 [PubMed - indexed for MEDLINE]Related articles